You are here

Article Text

Article menu
Download PDFPDF
PostScript
Correspondence
Defining the best time point to maximise the prognostic value of biomarkers
  1. Jose Angel Urbano-Moral,
  2. Jose Eduardo Lopez-Haldon
  1. Echocardiography Laboratory, Cardiology Division, Virgen del Rocio University Hospital, Seville, Spain
  1. Correspondence to Dr Jose Angel Urbano-Moral, Echocardiography Laboratory, Cardiology Division, Virgen del Rocio University Hospital, Manuel Siurot Avenue, Seville 41013, Spain; jaurbanomoral{at}gmail.com

https://doi.org/10.1136/heartjnl-2012-303082

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The Authors’ reply We appreciate the interest shown by Ferraro et al. 1 in our article recently published in Heart.2 They highlight that biomarker sampling time in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) might not have been suitable to yield the most reliable prognostic information. Ferrari and Panteghini, by referring to an article published by their group,3 underscore the significant role that both symptom onset-to-hospital admission time, and time of sampling play in troponin T, brain natriuretic peptide (BNP), and C reactive protein (CRP) release kinetics. We agree on this …

    View Full Text

    Footnotes

    • Contributors All authors have contributed to the conception and design, drafting of the text and final approval for submission.

    • Competing interests None.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles